U.S. Markets closed

After trial success, Alnylam plans to seek FDA approval for 2nd drug

Allison DeAngelis
After trial success, Alnylam plans to seek FDA approval for 2nd drug

The company announced Wednesday that its drug givosiran met its primary endpoints in a Phase 3 trial.